AMENDMENT 2 PH RFP 250104 VALLEY LEADERSHIP-SIGNED .PDF

Maricopa County — Formal (2026-11-18)

View PDF Item 82 Meeting page

Extracted text (via pymupdf_layout) 7759 characters
C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
AMENDMENT TO CONTRACT
BETWEEN MARICOPA COUNTY
BY AND THROUGH ITS
DEPARTMENT OF PUBLIC HEALTH
AND VALLEY LEADERSHIP CORPORATION
I. The purpose of this amendment is to add additional funding from the Overdose Data to
Action (OD2A) grant received by the Centers for Disease Control and Prevention (CDC)
and administered by the Maricopa County Department of Public Health. The contract is
currently funded with Opioid Settlement Funds (OSF), also administered by the Maricopa
County Department of Public Health.
II. The above-named contract is hereby amended as specified below:
A. Exhibit A-2 – YEAR 2 BUDGET SHEET & NARRATIVE shall be revised to include
Exhibit A-2 Addendum, Year 2 Overdose Data to Action (OD2A) (November 18,
2026 to June 30, 2027), appearing on page 3 of this amendment. This additional
amount constitutes the Overdose Data to Action (OD2A) portion that is being
added for Year 2.
B. Exhibit B – PRICING AND RESPONDENT INFORMATION shall be updated to add
an additional $120,000 of Overdose Data to Action (OD2A) Funding for the Year 2
budget period to begin November18, 2026 to June 30, 2027, making the total not-
to-exceed amount $819,996.
C. SECTION 4.0 AVAILABILITY OF FUNDS shall be updated with the following
language:
“4.3 All Overdose Data to Action (OD2A) Funds identified in Exhibit A-2, Addendum
Year 2 Budget Sheet and Narrative, shall be expended within the budget period
specified therein. Federal funds identified in the budget may carry forward at the
discretion of Maricopa County Department of Public Health to the extent permitted
by the funding agency.”
D. Exhibit C-2, Year 2 Scope of Work, shall be replaced with Exhibit C-3, Revised Year
2 Scope of Work (November 18, 2026 to June 30, 2027) beginning on page 7. This
updated scope of work includes deliverables from both funding sources.
E. Exhibit G, Unallowable Activities and Expenditures, has been newly added and
begins on page 16. It pertains to the newly added Overdose Data to Action
(OD2A) Funding.
Page 1 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
F. Exhibit H, Notice of Award, has been newly added and begins on page 18. This is
the award information that pertains to the newly added Overdose Data to Action
(OD2A) Funding.
III. All other terms and conditions of the original contract shall remain in full force and effect.
FOR AND ON BEHALF OF FOR AND ON BEHALF OF
MARICOPA COUNTY VALLEY LEADERSHIP CORPORATION
SIGN
By: By:
Chair, Board of Supervisors Valley Leadership Corporation
10/16/2026
Date Date
ATTEST
Clerk of the Board
Date
APPROVED AS TO FORM
Attorney for Maricopa County
Date
Page 2 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Exhibit A-2 Addendum
Year 2 OD2A Budget & Narrative
(November 18, 2026 – June 30, 2027)
Page 3 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 4 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 5 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 6 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Exhibit C-3
Revised Year 2 Scope of Work
(November 18, 2026 to June 30, 2027)
Page 7 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 8 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 9 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 10 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 11 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 12 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Exhibit G
UNALLOWABLE ACTIVITIES AND EXPENDITURES
This document is to give an overview of general unallowable activities and expenditures related
to overdose prevention under OD2A: LOCAL. While some of the activities listed below may
contribute to overdose prevention in some manner, they are either not allowed by HHS, CDC, or
congressional appropriations language. This is not an exhaustive list.
Activities related to harm reduction:
• Establish a new Syringe Services Program (SSPs)
• Infrastructure costs for SSPs except when contributing to co-location of treatment
(funds may be used for additional expenses associated with co-location)
• Provision of equipment solely intended for illegal drug use, such as
syringes, cookers/spoons, syringes, and pipes
• Procurement of other equipment solely intended for preparing drugs for illegal drug
injection, such as sterile water, filters, tourniquets, razors, straws, plastic cards, and
tiny spoons
• Safe injection sites (controlled environments that facilitate safer use of illicit drugs by
providing medical staff, clean facilities, and education) and developing educational
outreach and guidance or materials (including mass media, print, digital, or other)
about supervised injection facilities
• Purchasing and distributing fentanyl test strips for testing in biological samples
for clinical decision-making purposes
• Purchasing basic food, health, or personal items if not intended to support outreach
or engage individuals in venue-based programs (e.g., meal or grocery cards, first aid
kits, hygiene items, clothes, etc.)
• Pharmacy voucher program that provides participants with vouchers redeemable for
free syringes at participating pharmacies
Activities related to public health/public safety:
• Drug disposal, including the implementation or expansion of drug disposal
programs, drug take back programs, drug drop boxes, and drug disposal bags
• Purchase of handheld drug testing machines such as TruNarc, Fourier-transform
infrared (FTIR) machines, or HPMS machines for the purposes of reducing possible law
enforcement exposure to fentanyl
• Public safety activities that do not include overlap/collaboration with public
health partners and objectives
Page 13 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Activities related to health systems:
• Purchasing, leasing, or renting equipment intended to help EMS and other clinicians
treat and manage overdose
• Provision of SUD treatment that includes MOUD and the purchase of medications
such as Methadone, Buprenorphine, and Naltrexone
• Directly funding or expanding the provision of substance use treatment
• Paying for fees associated with clinicians obtaining waived status for DATA
waivers. This applies to direct reimbursements, contracts and waiver fees
• Financial incentives to encourage clinicians to participate in educational sessions
and training activities (e.g., participation in academic detailing, attending seminars,
completion of post-session surveys)
• Paying for the following services (only referral or linkage to them is allowed):
o Treatment for substance use disorder (MOUD)
o Behavioral therapy (e.g., cognitive behavioral therapy)
o Housing assistance
o Food assistance
o Medical care
• Specialized clinical care, if indicated, such as pain management Other generalized,
unallowable activities:
• Funding or subsidizing costs associated with programs other than those
specifically targeting overdose prevention
• Childcare and childcare-related purchases (e.g. pack-n-play)
• Furniture or equipment (purchase or leasing vehicles may be allowable expenses
for linkage to care activities)
• Research
• Prevention of Adverse Childhood Experiences (ACEs) as a standalone activity
Funding cannot be used to directly fund or expand the direct provision of substance use
disorder treatment programs. Such activities are outside the scope of this grant.
Page 14 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Exhibit H
Notice of Award
Page 15 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 16 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 17 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 18 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 19 of 20

C-86-26-041-X-01 / PH RFP 250104 AMENDMENT 2
Page 20 of 20